Professional Documents
Culture Documents
1
PHARMACOLOGY
b) unStable Angina
c) variant Angina
d) none
13. phosphoiesterase inhibitor used in CHF
a) Amrinone
b) Milrinone
c) A&b
d) Dobutamine
14. Increase in potassium ion concentration
a) Decrease effect of cardiac glycosides
b) increase effect of cardiac glycosides
c) no effect of cardiac glycosides
d) none
15. Hormone used in treatment of CHF
a) Insulin
b) Glucagon
c) Stomatostatin
d) All of above
16. Diuretic as aldosterone antagonist
a) Furosemide
b) Sironolactone
c) Dichlorothiazide
d) Captopril
17. Vasodilator which releases NO
a) Nifedipine
b) Hydralazine
c) Minoxidil
d) Sodium nitroprusside
18. Hydralazine can produce
a) Seizures
b) Tachycardia
c) Hepatitis
d) Aplastic anaemia
19. Endogenous vasoconstrictor stimulates aldosterone release from glands
a) Angiotensinogen
b) Angiotensin-I
c) Angiotensin-II
d) ACE
20. Use of beta blockers for hypertensive treatment is
a) Peripheral vasodilation
b) Diminishing blood volume
c) Decrease of heart work
d) Depression of vasomotor centre
2
PHARMACOLOGY